Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Doxofylline (400mg) + Salbutamol (2mg) Tablet
Therapeutic Category
Asthma, Pulmonary, Respiratory
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dozyfyle S Tablet containing Doxofylline and Salbutamol is used for the management of asthma, bronchospasm, and other respiratory conditions associated with breathing difficulty. It helps improve airflow and respiratory comfort.
Doxofylline works as a bronchodilator that relaxes airway muscles, while Salbutamol helps open narrowed air passages and supports easier breathing.
The tablet is widely prescribed in respiratory and pulmonary care practice for chronic airway disorders, leading to consistent prescription demand.
With increasing prevalence of asthma and respiratory disorders, this product offers strong business potential for retailers and distributors. Its dual bronchodilator action, broad clinical relevance, and steady market demand make it a reliable product for growth in the respiratory segment.
Some patients may experience tremors, headache, nausea, palpitations, nervousness, or dizziness. Rarely, rapid heartbeat or allergic reactions may occur and require medical attention.
Dozyfyle S Tablet is indicated for asthma, chronic obstructive pulmonary disease (COPD), bronchitis, wheezing, and other respiratory conditions associated with bronchospasm. It helps improve breathing, reduce wheezing, relieve chest tightness, and enhance airflow.
This medicine should be used under medical supervision. Use cautiously in patients with heart disease, high blood pressure, diabetes, or thyroid disorders. Do not exceed the prescribed dose.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Doxofylline (400mg)
Composition : Doxofylline (400mg) + Montelukast (10mg)
Composition : Doxofylline (650mg) SR
Composition : Formoterol (12mcg) + Tiotropium (18mcg)
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)
Composition : Levosalbutamol (50mcg) + Ipratropium (20mcg)
Composition : Tiotropium (9mcg)
Composition : Levosalbutamol (0.5mg/5ml) + Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Dozyfyle S Tablet, containing Doxofylline 400mg and Salbutamol 2mg, has strong demand in the respiratory and anti-asthmatic segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on chest care and pulmonary disease management portfolios.
Medical distributors and agencies can benefit from the consistent demand for bronchodilator combination therapies used in asthma, COPD, bronchospasm, wheezing, and breathing difficulty. The combination helps improve airway relaxation and breathing capacity, strengthening a comprehensive respiratory care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Dozyfyle S Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong respiratory prescription demand, seasonal asthma/COPD sales, reliable supply chain support, and good margins when partnering for Dozyfyle S Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Dozyfyle S Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.